The PI3K/AKT signaling pathway is involved in tumor progression in various types of cancer, including ESCC [37, 38]; however, its relationship with HERG1 and TXNDC5 remains unclear. This evidence concerns the gene TXNDC5 and esophageal squamous cell carcinoma.